CHANGES IN BLOOD-COAGULATION AND FIBRINOLYSIS IN PATIENTS ON DIFFERENT TREATMENT REGIMENS FOR PROSTATIC-CANCER - PREDICTORS FOR CARDIOVASCULAR COMPLICATIONS

被引：28

作者：

BLOMBACK, M

HEDLUND, PO

SAWE, U

机构：

[1] KAROLINSKA HOSP,DEPT UROL,S-10401 STOCKHOLM 60,SWEDEN

[2] AB LEO,DEPT MED,S-25100 HELSINGBORG,SWEDEN

来源：

THROMBOSIS RESEARCH | 1988年 / 49卷 / 01期

关键词：

D O I：

10.1016/0049-3848(88)90364-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：111 / 121

页数：11

共 25 条

[1] ANTITHROMBIN (HEPARIN COFACTOR) ASSAY WITH NEW CHROMOGENIC SUBSTRATES (S-2238 AND CHROMOZYM-TH) [J].

ABILDGAARD, U ;

LIE, M ;

ODEGARD, OR .

THROMBOSIS RESEARCH, 1977, 11 (04) :549-553

[2] THE INFLUENCE OF TREATMENT WITH ESTROGENS AND ESTRAMUSTINE PHOSPHATE ON PLATELET-AGGREGATION AND PLASMA-LIPOPROTEINS IN NON-DISSEMINATED PROSTATIC-CARCINOMA [J].

AGARDH, CD ;

NILSSONEHLE, P ;

LUNDGREN, R ;

GUSTAFSON, A .

JOURNAL OF UROLOGY, 1984, 132 (05) :1021-1024

[3]

BACHMANN F, 1958, THROMB DIATH HAEMOST, V2, P24

[4]

BLOMBACK M, 1983, PEDIATRICS, V72, P416

[5] ESTROGEN-INDUCED DEFICIENCY AND DECREASE IN ANTITHROMBIN III ACTIVITY IN PATIENTS WITH PROSTATIC-CANCER [J].

BULLER, HR ;

BOON, TA ;

HENNY, CP ;

DABHOIWALA, NF ;

TENCATE, JW .

JOURNAL OF UROLOGY, 1982, 128 (01) :72-74

[6]

BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO

[7]

2-C

[8] EVIDENCE FOR A RAPID INHIBITOR TO TISSUE PLASMINOGEN-ACTIVATOR IN PLASMA [J].

CHMIELEWSKA, J ;

RANBY, M ;

WIMAN, B .

THROMBOSIS RESEARCH, 1983, 31 (03) :427-436

[9]

HAMSTEN A, 1986, BRIT HEART J, V55, P58

[10]

Hedlund P O, 1980, Scand J Urol Nephrol Suppl, V55, P103

← 1 2 3 →